<DOC>
	<DOCNO>NCT01788384</DOCNO>
	<brief_summary>Acanya ( Clindamycin Phosphate Benzoyl Peroxide ) Gel , 1.2 % /2.5 % gel market Valeant Pharmaceuticals , North America , safe effective topical therapy use treatment acne vulgaris .</brief_summary>
	<brief_title>Evaluate Therapeutic Equivalence Safety Two Clindamycin Phosphate Benzoyl Peroxide Gels Acne Vulgaris</brief_title>
	<detailed_description>Watson Laboratories , Inc. develop generic formulation Clindamycin Phosphate Benzoyl Peroxide Gel , 1.2 % /2.5 % , current study design evaluate safety efficacy formulation determine bioequivalent Acanya .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>Healthy male non pregnant female ≥ 12 ≤ 40 year Diagnosis acne vulgaris ( acne ) &gt; 18 year provide write informed consent Ages 12 17 provide write assent write informed consent patient 's legal representative Must sign HIPAA authorization Minimum ≥ 25 noninflammatory lesion ≥ 20 inflammatory lesion ≤ 2 nodulocystic lesion face Acne severity grade 2 , 3 , 4 Investigator 's Global Assessment ( IGA ) Refrain topical acne medication antibiotics 12week treatment period except Investigational Product All Female patient negative urine pregnancy test use birth control study start 30 day last administration study drug All male patient use birth control partner , study start 30 day last administration study drug . Abstinence acceptable . Female partner use birth control Must willing able understand comply protocol requirement require study visit In good health Free clinically significant disease Must use brands/types makeup minimum period 14 day prior study entry must agree use makeup , brand/type maintain frequency use throughout study Female patient pregnant , nurse plan become pregnant study History presence Crohn 's disease , ulcerative colitis , regional enteritis , antibioticassociated colitis Hypersensitivity allergy benzoyl peroxide , clindamycin and/or study medication ingredient Presence skin condition would interfere diagnosis assessment Excessive facial hair Wax epilation face within 14 day prior Used oral retinoids therapeutic vitamin A supplement &gt; 10,000 units/day ( multivitamin allow ) within 6 month prior study Estrogens oral contraceptive &lt; 3 month prior baseline ; Use therapy must remain constant throughout study Cryodestruction , chemodestruction , dermabrasion , photodynamic therapy , acne surgery , intralesional steroid , Xray therapy procedure perform face within 1 month prior study Any systemic ( steroid , antibiotic treatment acne , antiinflammatory agent ) treatment within 1 month prior baseline study Any ( topical steroid , topical retinoids , αhydroxy/glycolic acid , benzoyl peroxide , topical antiinflammatory agent , topical antibiotic ) treatment within 2 week prior baseline study : Intend use Spironolactone Intend use tan booth , sunbathe , excessive exposure sun Radiation therapy and/or antineoplastic agent within 90 day prior baseline Unstable clinically significant medical disorder lifethreatening disease Ongoing malignancy require systemic treatment Any malignancy facial area skin Engage activity involve excessive prolonged exposure sunlight weather extreme Consume excessive amount alcohol use drug abuse Participation investigational drug study within 30 day prior Are participate nontreatment study observational study registry study consider inclusion Previously enrol study Laser therapy , electrodessication phototherapy facial area within 180 day prior study entry Cosmetic procedure may affect efficacy safety profile study drug within 14 day prior study entry Currently recently bacterial folliculitis face</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>acne</keyword>
	<keyword>Clindamycin Phosphate/Benzoyl Peroxide</keyword>
	<keyword>Acanya</keyword>
	<keyword>Mild severe acne vulgaris</keyword>
</DOC>